CRESCO is a Centre of Excellence funded by the Norwegian Research Council. We combine complementary expertise on epigenetic and epitranscriptomic modifications, DNA repair and genome (in)stability, single-cell and single-nucleotide analysis, embryology and healthy development.
Company Details
- Employees
- 7
- Founded
- -
- Address
- Forskningsveien 1, Vestre Aker,oslo 0373,norway
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Vestre Aker, Oslo
- Competitors
- Precision Immunotherapy Alliance, PRIMA, Kripthonite Therapeutics, Zenit Science, ARTBIO, Marigold Investment Management, ZYGOTE - increased research capacity in applied biotechnology, PrecisionPhage, GIAMAG Technologies, CanCell - Center for Cancer Cell Reprogramming, Thermo Fisher Scientific.
Cresco - Centre For Embryology And Healthy Development Questions
Cresco - Centre For Embryology And Healthy Development's website is https://www.cresco.uio.no/english/
Cresco - Centre For Embryology And Healthy Development's LinkedIn profile is https://no.linkedin.com/company/cresco-centre-for-embryology-and-healthy-development
Cresco - Centre For Embryology And Healthy Development has
7 employees.
View email and phone details for 7
employees at Cresco - Centre For Embryology And Healthy Development.
Cresco - Centre For Embryology And Healthy Development's industry is
Biotechnology Research
Cresco - Centre For Embryology And Healthy Development's top competitors are
Precision Immunotherapy Alliance, Prima,
Kripthonite Therapeutics,
Zenit Science,
Artbio,
Marigold Investment Management,
Zygote - Increased Research Capacity In Applied Biotechnology,
Precisionphage,
Giamag Technologies,
Cancell - Center For Cancer Cell Reprogramming,
Thermo Fisher Scientific.
Cresco - Centre For Embryology And Healthy Development's categories are Biotechnology Research
Cresco - Centre For Embryology And Healthy Development's founding year is 2023
